Recursion Pharmaceuticals Registers Resale of Tempus Shares
Less than 1 min read
On November 26, 2025, Recursion Pharmaceuticals announced the registration for resale of 7,088,742 shares of Class A common stock.
Key Highlights:
- Shares issued to Tempus AI for annual license fees.
- Resale registered under automatic shelf registration.
- Offering made under exemption from Securities Act.
Original SEC Filing: RECURSION PHARMACEUTICALS, INC. [ RXRX ] - 8-K - Nov. 26, 2025
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.